Fierce Fatty Podcast cover image

155: Part 1: Is Wegovy/Ozempic the Miracle Weight Loss Drug It’s Made Out to Be?

Fierce Fatty Podcast

CHAPTER

Novo Nordisk: Weight Loss and Ethical Dilemmas

This chapter examines Novo Nordisk's rise within the weight loss drug market, particularly focusing on Wegovy and Ozempic. It critiques the ethical implications of their marketing practices and the societal narratives surrounding fatness, while highlighting the company's controversial history and pricing strategies.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner